These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 27065960)
1. Interactions between Trypanosoma cruzi Secreted Proteins and Host Cell Signaling Pathways. Watanabe Costa R; da Silveira JF; Bahia D Front Microbiol; 2016; 7():388. PubMed ID: 27065960 [TBL] [Abstract][Full Text] [Related]
2. Cruzipain Activates Latent TGF-β from Host Cells during T. cruzi Invasion. Ferrão PM; d'Avila-Levy CM; Araujo-Jorge TC; Degrave WM; Gonçalves Ada S; Garzoni LR; Lima AP; Feige JJ; Bailly S; Mendonça-Lima L; Waghabi MC PLoS One; 2015; 10(5):e0124832. PubMed ID: 25938232 [TBL] [Abstract][Full Text] [Related]
3. A new cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes. Aparicio IM; Scharfstein J; Lima AP Infect Immun; 2004 Oct; 72(10):5892-902. PubMed ID: 15385491 [TBL] [Abstract][Full Text] [Related]
4. Lipoproteins from vertebrate host blood plasma are involved in Trypanosoma cruzi epimastigote agglutination and participate in interaction with the vector insect, Rhodnius prolixus. Moreira CJC; De Cicco NNT; Galdino TS; Feder D; Gonzalez MS; Miguel RB; Coura JR; Castro HC; Azambuja P; Atella GC; Ratcliffe NA; Mello CB Exp Parasitol; 2018 Dec; 195():24-33. PubMed ID: 30261188 [TBL] [Abstract][Full Text] [Related]
5. Review on Trypanosoma cruzi: Host Cell Interaction. de Souza W; de Carvalho TM; Barrias ES Int J Cell Biol; 2010; 2010():. PubMed ID: 20811486 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive glycoprofiling of the epimastigote and trypomastigote stages of Trypanosoma cruzi. Alves MJ; Kawahara R; Viner R; Colli W; Mattos EC; Thaysen-Andersen M; Larsen MR; Palmisano G J Proteomics; 2017 Jan; 151():182-192. PubMed ID: 27318177 [TBL] [Abstract][Full Text] [Related]
9. Roles of naturally occurring protease inhibitors in the modulation of host cell signaling and cellular invasion by Trypanosoma cruzi. Scharfstein J; Lima AP Subcell Biochem; 2008; 47():140-54. PubMed ID: 18512348 [TBL] [Abstract][Full Text] [Related]
10. MIF-driven activation of macrophages induces killing of intracellular Trypanosoma cruzi dependent on endogenous production of tumor necrosis factor, nitric oxide and reactive oxygen species. Cutrullis RA; Petray PB; Corral RS Immunobiology; 2017 Feb; 222(2):423-431. PubMed ID: 27591076 [TBL] [Abstract][Full Text] [Related]
11. Extracellular Vesicles: Potential Role in Remote Signaling and Inflammation in Dantas-Pereira L; Menna-Barreto R; Lannes-Vieira J Front Cell Dev Biol; 2021; 9():798054. PubMed ID: 34988085 [TBL] [Abstract][Full Text] [Related]
13. Evasion of the Immune Response by Trypanosoma cruzi during Acute Infection. Cardoso MS; Reis-Cunha JL; Bartholomeu DC Front Immunol; 2015; 6():659. PubMed ID: 26834737 [TBL] [Abstract][Full Text] [Related]
14. Theft and Reception of Host Cell's Sialic Acid: Dynamics of da Fonseca LM; da Costa KM; Chaves VS; Freire-de-Lima CG; Morrot A; Mendonça-Previato L; Previato JO; Freire-de-Lima L Front Immunol; 2019; 10():164. PubMed ID: 30787935 [TBL] [Abstract][Full Text] [Related]
15. Experimental Chagas disease. Innate immune response in Balb/c mice previously vaccinated with Trypanosoma rangeli. I. The macrophage shows immunological memory: Reality or fiction? Basso B; Marini V Immunobiology; 2014 Apr; 219(4):275-84. PubMed ID: 24321621 [TBL] [Abstract][Full Text] [Related]
16. Evasion of immune responses by Trypanosoma cruzi, the etiological agent of Chagas disease. DosReis GA Braz J Med Biol Res; 2011 Feb; 44(2):84-90. PubMed ID: 21243314 [TBL] [Abstract][Full Text] [Related]
18. Trypanosoma cruzi: Entry into Mammalian Host Cells and Parasitophorous Vacuole Formation. Barrias ES; de Carvalho TM; De Souza W Front Immunol; 2013; 4():186. PubMed ID: 23914186 [TBL] [Abstract][Full Text] [Related]
19. Proteolytic cleavage of chemokines by Trypanosoma cruzi's cruzipain inhibits chemokine functions by promoting the generation of antagonists. Benítez-Hernández I; Méndez-Enríquez E; Ostoa P; Fortoul T; Ramírez JA; Stempin C; Cerbán F; Soldevila G; García-Zepeda EA Immunobiology; 2010 May; 215(5):413-26. PubMed ID: 19581017 [TBL] [Abstract][Full Text] [Related]
20. The challenge of Chagas' disease: has the human pathogen, Trypanosoma cruzi, learned how to modulate signaling events to subvert host cells? Lima FM; Oliveira P; Mortara RA; Silveira JF; Bahia D N Biotechnol; 2010 Dec; 27(6):837-43. PubMed ID: 20172059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]